DocMorris Ltd. engages in the operation of an e-commerce pharmacy and the wholesale of medical and pharmaceutical products. The company is headquartered in Frauenfeld, Thurgau. The company went IPO on 2017-07-06. The firm focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The firm's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
How did ZRSEF's recent EPS compare to expectations?
The most recent EPS for DocMorris AG is $, expectations of $.
How did DocMorris AG ZRSEF's revenue perform in the last quarter?
DocMorris AG revenue for the last quarter is $
What is the revenue estimate for DocMorris AG?
According to of Wall street analyst, the revenue estimate of DocMorris AG range from $ to $
What's the earning quality score for DocMorris AG?
DocMorris AG has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does DocMorris AG report earnings?
DocMorris AG next earnings report is expected in 2026-06-17
What are DocMorris AG's expected earnings?
DocMorris AG expected earnings is $, according to wall-street analysts.